Morgan Stanley
OPTR

Morgan Stanley’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Morgan Stanley’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,473,360
Closed -$18.6M – 6448
2013
Q3 		$18.6M Buy
1,473,360
+1,460,943
+11,766% +$19.4M 0.01% 1282
2013
Q2 		$180K Buy
+12,417
New +$181K ﹤0.01% 4891

Morgan Stanley's OPTR Position: Q4 2013 in Review

Morgan Stanley sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 1,473,360 shares — an estimated $18.6M sold.

Morgan Stanley first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $18.6M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Morgan Stanley reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Morgan Stanley sold 1,473,360 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $18.6M.
  • Morgan Stanley first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Morgan Stanley's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $18.6M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Morgan Stanley's 13F filing for Q4 2013, filed 13 Feb 2014.